Glenmark Pharmaceuticals Limited focuses on developing, manufacturing, selling and distribution of branded generics. From APIs to front end marketing capabilities, Glenmark’ s businesses are vertically integrated into the generics market, by focusing on key niche segments including Dermatology, Hormones, Controlled Substances, Oncology and Modified Release Products.

Glenmark is a research-driven company and is a leading player in the discovery of new molecules, both NCEs (new chemical entity) and NBEs (new biological entity), with seven molecules in various stages of clinical development & pre-clinical development. The company has a significant presence in branded generics markets across emerging economies including India.

Its subsidiary, Glenmark Generics Limited has a fast growing and robust US generics business. The subsidiary also markets APIs to regulated and semi-regulated countries. Glenmark employs over 10,400 people in over 80 countries. It has 14 manufacturing facilities in four countries and has 6 R&D centres.

Ultra-Pharm Marketing Limited is the sole distributor of Glenmark in Trinidad and Tobago and has been providing this quality generic to the local market since 2007. During this time, the brand has established itself amongst local consumers, who purchase their over the counter offerings, and amongst Doctors who readily prescribe these products to their valued customers.

[fc id=’2′ type=’slide’ placement=’bottom-right’ button_color=’#4488ee’ font_color=’white’]Contact a Sales Rep[/fc]